thiazoles has been researched along with Antibiotic-Associated Colitis in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, MP; Debast, SB; Kuijper, EJ; Sanders, IM; Wilcox, MH | 1 |
| Bressler, AM; Johnson, DP; Logan, N; Musher, DM; Rossignol, JF | 1 |
| Johnson, AP | 1 |
| Bookstaver, PB; Miller, AD; Musgrave, CR; Sutton, SS | 1 |
| Citron, DM; Goldstein, EJ; Merriam, CV; Tyrrell, KL | 1 |
| Amaral, A; Brewer, JT; Bushell, SM; Deng, G; Dewhurst, JM; Ding, J; Dzink-Fox, J; Gamber, G; Jain, A; LaMarche, MJ; Lee, K; Lee, L; Leeds, JA; Lister, T; McKenney, D; Mullin, S; Osborne, C; Palestrant, D; Patane, MA; Rann, EM; Sachdeva, M; Shao, J; Tiamfook, S; Trzasko, A; Whitehead, L; Yan, W; Yifru, A; Yu, D; Zhu, Q | 1 |
| Lamarche, MJ; Leeds, JA; McKenney, D; Praestgaard, J; Trzasko, A | 1 |
| Dzink-Fox, J; Lamarche, MJ; Leeds, JA; Mullin, S; Sachdeva, M | 1 |
| Guerrant, RL; Hoffman, PS; Kolling, GL; Li, Y; Moore, JH; Riggins, MS; van Opstal, EJ; Warren, CA | 1 |
| Dupont, HL; Gupta, A; Hamill, RJ; Lentnek, A; Logan, N; Musher, DM; Rossignol, JF | 1 |
| Koletar, SL; Mangino, JE; Stevenson, KB; Young, JD | 1 |
| Garud, S; Hamill, RJ; Logan, N; Mehendiratta, V; Melgarejo, NA; Musher, DM | 1 |
| McVay, CS; Rolfe, RD | 1 |
| Arya, SC | 1 |
2 review(s) available for thiazoles and Antibiotic-Associated Colitis
| Article | Year |
|---|---|
New antibiotics for selective treatment of gastrointestinal infection caused by Clostridium difficile.
Topics: Aminoglycosides; Anti-Bacterial Agents; Benzopyrans; Clostridioides difficile; Enterocolitis, Pseudomembranous; Fidaxomicin; Glycopeptides; Humans; Lipoglycopeptides; Nitro Compounds; Thiazoles; Thiophenes | 2010 |
Use of alternative or adjuvant pharmacologic treatment strategies in the prevention and treatment of Clostridium difficile infection.
Topics: Aminoglycosides; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Immunotherapy; Nitro Compounds; Polymers; Probiotics; Thiazoles | 2011 |
3 trial(s) available for thiazoles and Antibiotic-Associated Colitis
| Article | Year |
|---|---|
Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Double-Blind Method; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Nitro Compounds; Prospective Studies; Thiazoles; Treatment Outcome; United States; Vancomycin | 2009 |
Nitazoxanide for the treatment of Clostridium difficile colitis.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Nitro Compounds; Thiazoles | 2006 |
Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Nitro Compounds; Recurrence; Thiazoles; Treatment Failure | 2007 |
9 other study(ies) available for thiazoles and Antibiotic-Associated Colitis
| Article | Year |
|---|---|
Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Enterocolitis, Pseudomembranous; Europe; Fidaxomicin; Humans; Metronidazole; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymerase Chain Reaction; Ribotyping; Thiazoles; Treatment Outcome; Vancomycin | 2013 |
Comparative in vitro activities of LFF571 against Clostridium difficile and 630 other intestinal strains of aerobic and anaerobic bacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Clostridioides difficile; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Intestines; Microbial Sensitivity Tests; Microbial Viability; Peptide Elongation Factor Tu; Protein Biosynthesis; Species Specificity; Thiazoles | 2012 |
Discovery of LFF571: an investigational agent for Clostridium difficile infection.
Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Cricetinae; Crystallography, X-Ray; Enterococcus; Enterocolitis, Pseudomembranous; Escherichia coli Proteins; Female; Male; Mesocricetus; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Peptide Elongation Factor Tu; Rats; Rats, Sprague-Dawley; Solubility; Staphylococcus aureus; Streptococcus pyogenes; Structure-Activity Relationship; Thiazoles; Water | 2012 |
Efficacy of LFF571 in a hamster model of Clostridium difficile infection.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Cricetinae; Enterocolitis, Pseudomembranous; Enterotoxins; Male; Mesocricetus; Recurrence; Thiazoles; Vancomycin | 2012 |
Mechanism of action of and mechanism of reduced susceptibility to the novel anti-Clostridium difficile compound LFF571.
Topics: Anti-Bacterial Agents; Binding Sites; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Humans; Microbial Sensitivity Tests; Peptide Chain Elongation, Translational; Peptide Elongation Factor Tu; Protein Structure, Tertiary; Thiazoles | 2012 |
Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacteroides; Cecum; Clostridioides difficile; Clostridium Infections; DNA, Bacterial; Enterocolitis, Pseudomembranous; Feces; Fidaxomicin; Intestines; Male; Metronidazole; Mice; Mice, Inbred C57BL; Nitro Compounds; Recurrence; Thiazoles; Treatment Outcome; Vancomycin | 2013 |
Nitazoxanide versus metronidazole for Clostridium difficile-associated colitis.
Topics: Aged; Animals; Anti-Bacterial Agents; Clostridioides difficile; Cricetinae; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Nitro Compounds; Thiazoles; Treatment Outcome | 2007 |
In vitro and in vivo activities of nitazoxanide against Clostridium difficile.
Topics: Animals; Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Cricetinae; Disease Models, Animal; Enterocolitis, Pseudomembranous; Metronidazole; Microbial Sensitivity Tests; Nitro Compounds; Thiazoles; Vancomycin | 2000 |
Nitazoxanide as a broad-spectrum antiparasitic agent.
Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Cricetinae; Enterocolitis, Pseudomembranous; Humans; Middle Aged; Nitro Compounds; Parasites; Parasitic Diseases; Thiazoles | 2002 |